Literature DB >> 23184501

TNFSF4 gene polymorphism rs3861950 but not rs3850641 is associated with the risk of cerebral infarction in a Chinese population.

Jie Feng1, Yun-Hai Liu, Qi-Dong Yang, Zan-Hua Zhu, Kun Xia, Xing-Lin Tan, Jian Xia, Wen-Ping Gu, Lin Zhou, Bo Xiao, Bei-Sha Tang, Qing Huang.   

Abstract

Tumor necrosis factor superfamily member 4 (TNFSF4) plays a key role in the process of atherosclerosis, a common risk factor for both myocardial and cerebral infarctions. Recent studies indicate that the single nucleotide polymorphism (SNP) rs3850641 in TNFSF4 is associated with higher risk of myocardial infarction, but little is known about the association between TNFSF4 variation and cerebral infarction (CI). A case-control study involving 385 CI patients and 385 age-matched, sex-matched non-CI controls was conducted in a Chinese population, only the most common subtype, atherosclerosis CI, was recruited. Two SNPs of TNFSF4, rs3850641 and rs3861950, were genotyped by the TaqMan SNP genotyping method, and verified partly by genomic DNA sequencing. The results revealed a significant allelic association between rs3861950 and CI (Odds ration = 1.733, 95 % confidence interval = 1.333-2.254, P = 0.000). Genotypic association analysis demonstrated that the CC genotype of rs3861950 confers susceptibility to CI (Odds ration = 2.896, 95 % confidence interval = 1.368-6.132), and it was associated with a significantly higher risk of ischemic stroke (Odds ration = 3.520, 95 % confidence interval = 1.546-8.015, P = 0.003) after adjusting for the other confirmed risk factors such as the history of hypertension, diabetes, CAD, smoking and alcohol drinking. While the odds ratio of the T allele to the C allele was 1.733 (95 % confidence interval: 1.333-2.254). However, there was no significant association between rs3850641 and CI (Odds ration = 1.288, 95 % confidence interval = 0.993-1.670, P = 0.056). TNFSF4 gene polymorphism rs3861950, but not rs3850641, is associated with the risk of atherosclerosis CI in a Chinese population.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23184501     DOI: 10.1007/s11239-012-0849-9

Source DB:  PubMed          Journal:  J Thromb Thrombolysis        ISSN: 0929-5305            Impact factor:   2.300


  21 in total

1.  Human genetic evidence that OX40 is implicated in myocardial infarction.

Authors:  Massimiliano Ria; Per Eriksson; Susanna Boquist; Carl-Göran Ericsson; Anders Hamsten; Jacob Lagercrantz
Journal:  Biochem Biophys Res Commun       Date:  2005-11-28       Impact factor: 3.575

2.  Lack of support for association between common variation in TNFSF4 and myocardial infarction in a German population.

Authors:  Werner Koch; Petra Hoppmann; Jakob C Mueller; Albert Schömig; Adnan Kastrati
Journal:  Nat Genet       Date:  2008-12       Impact factor: 38.330

3.  Association of OX40 and OX40L gene polymorphisms with acute coronary syndrome in a Han Chinese population.

Authors:  Yucheng Chen; Li Zhang; Hao Huang; Rui Liu; Xian Li; Ou Qiang; Zhi Zeng
Journal:  DNA Cell Biol       Date:  2011-04-10       Impact factor: 3.311

4.  Genetic risk for atherothrombotic cerebral infarction in individuals stratified by sex or conventional risk factors for atherosclerosis.

Authors:  Sachiyo Yamaguchi; Yoshiji Yamada; Norifumi Metoki; Hidemi Yoshida; Kei Satoh; Sahoko Ichihara; Kimihiko Kato; Takashi Kameyama; Kiyoshi Yokoi; Hitoshi Matsuo; Tomonori Segawa; Sachiro Watanabe; Yoshinori Nozawa
Journal:  Int J Mol Med       Date:  2006-11       Impact factor: 4.101

5.  Association of blood monocyte and platelet markers with carotid artery characteristics: the atherosclerosis risk in communities carotid MRI study.

Authors:  N Matijevic; K K Wu; A G Howard; B Wasserman; W Y-W Wang; A R Folsom; A R Sharrett
Journal:  Cerebrovasc Dis       Date:  2011-04-12       Impact factor: 2.762

6.  Lymphotoxin beta receptor-dependent control of lipid homeostasis.

Authors:  James C Lo; Yugang Wang; Alexei V Tumanov; Michelle Bamji; Zemin Yao; Catherine A Reardon; Godfrey S Getz; Yang-Xin Fu
Journal:  Science       Date:  2007-04-13       Impact factor: 47.728

Review 7.  A review of genetic causes of ischemic and hemorrhagic stroke.

Authors:  Martijn Tonk; Joost Haan
Journal:  J Neurol Sci       Date:  2007-02-27       Impact factor: 3.181

8.  Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment.

Authors:  H P Adams; B H Bendixen; L J Kappelle; J Biller; B B Love; D L Gordon; E E Marsh
Journal:  Stroke       Date:  1993-01       Impact factor: 7.914

9.  Serial measurement of surface expressions of CD63, P-selectin and CD40 ligand on platelets in atherosclerotic ischemic stroke. A possible role of CD40 ligand on platelets in atherosclerotic ischemic stroke.

Authors:  Jae-Kwan Cha; Min-Ho Jeong; Ji-Yeon Jang; Hae-Rahn Bae; Yeong-Jin Lim; Jung Sun Kim; Sang-Ho Kim; Jae Woo Kim
Journal:  Cerebrovasc Dis       Date:  2003       Impact factor: 2.762

Review 10.  Genetic risk factors for stroke and carotid atherosclerosis: insights into pathophysiology from candidate gene approaches.

Authors:  Steve E Humphries; Laleh Morgan
Journal:  Lancet Neurol       Date:  2004-04       Impact factor: 44.182

View more
  3 in total

1.  Lack of association of tumor necrosis factor superfamily member 4 (TNFSF4) gene polymorphisms (rs3850641 and rs17568) with coronary heart disease and stroke: A systematic review and meta-analysis.

Authors:  Jin Sen Lu; Hong Wang; Fei Fei Yuan; Le Le Wu; Bin Wang; Dong Qing Ye
Journal:  Anatol J Cardiol       Date:  2018-02       Impact factor: 1.596

2.  A Meta-Analysis on the Association Between TNFSF4 Polymorphisms (rs3861950 T > C and rs1234313 A > G) and Susceptibility to Coronary Artery Disease.

Authors:  Shuyan Liu; Xiju Wang; Shoujun Yu; Miao Yan; Yue Peng; Guilong Zhang; Zhaowei Xu
Journal:  Front Physiol       Date:  2020-11-26       Impact factor: 4.566

3.  Sex-specific and opposite modulatory aspects revealed by PPI network and pathway analysis of ischemic stroke in humans.

Authors:  Yan Lv; X Y He; Dongguo Li; Tao Liu; G Q Wen; Junfa Li
Journal:  PLoS One       Date:  2020-01-03       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.